Jane Street’s Vera Therapeutics VERA Stock Holding History

Jane Street’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$463K	Buy	+10,800	New	+$402K	﹤0.01%	8194
2026 Q1	–	Sell	-67,600	Closed	-$3.42M	–	13091
2025 Q4	$3.42M	Buy	67,600 +2,300	+4%	+$81.7K	﹤0.01%	3827
2025 Q3	$1.9M	Sell	65,300 -31,300	-32%	-$724K	﹤0.01%	5035
2025 Q2	$2.28M	Buy	+96,600	New	+$2.17M	﹤0.01%	4222
2025 Q1	–	Sell	-43,000	Closed	-$1.82M	–	10689
2024 Q4	$1.82M	Sell	43,000 -3,000	-7%	-$133K	﹤0.01%	4285
2024 Q3	$2.03M	Sell	46,000 -3,000	-6%	-$114K	﹤0.01%	4435
2024 Q2	$1.77M	Sell	49,000 -17,300	-26%	-$686K	﹤0.01%	4705
2024 Q1	$2.86M	Buy	+66,300	New	+$2.36M	﹤0.01%	3481
2023 Q3	–	Sell	-27,600	Closed	-$443K	–	9457
2023 Q2	$443K	Buy	+27,600	New	+$249K	﹤0.01%	6497

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jane Street's VERA Position: Q2 2026 in Review

Jane Street sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 21,150 shares — an estimated $788K sold.

Jane Street first reported a position in VERA in Q4 2021 and held it in 10 quarters. The position peaked at $5.35M in Q2 2024. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Jane Street reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
Jane Street sold 21,150 Vera Therapeutics shares in Q2 2026, an estimated $788K.
Jane Street first reported a position in Vera Therapeutics in Q4 2021 and held it in 10 quarters.
Jane Street's Vera Therapeutics position peaked at $5.35M in Q2 2024.
220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.